Concepedia

Charles R. Heap

CR

Statistics

Publications

6

Citations

186

H-Index

6

Active since

1996

Affiliations

Albany Molecular Research (United States)(Current)

Eli Lilly (United States)

Charles R. Heap is an author at Albany Molecular Research (United States) specializing in natural sciences, medicinal chemistry, and drug discovery.

Publications per year

1996–2014

6

Publications

6

Optimization of a Dihydropyrrolopyrazole Series of Transforming Growth Factor-β Type I Receptor Kinase Domain Inhibitors: Discovery of an Orally Bioavailable Transforming Growth Factor-β Receptor Type I Inhibitor as Antitumor Agent

Hongyu Li, William T. McMillen, Charles R. Heap et al. · Journal of Medicinal Chemistry · 2008 · 66 citations · Full text

, , +13

Dihydropyrrolopyrazole Transforming Growth Factor-β Type I Receptor Kinase Domain Inhibitors:  A Novel Benzimidazole Series with Selectivity versus Transforming Growth Factor-β Type II Receptor Kinase and Mixed Lineage Kinase-7

Hongyu Li, Yan Wang, Charles R. Heap et al. · Journal of Medicinal Chemistry · 2006 · 48 citations · Full text

, , +13

Total synthesis of Resolvin E1

Melissa Allard, Keith D. Barnes, Xue‐Mei Chen et al. · Tetrahedron Letters · 2011 · 32 citations

, , +4

Cyclic hydropyran oligolides as preorganized ligand arrays: Modular assembly of 18-, 24-, 36-, 48-, 54- and 72-membered rings via iteration and cyclooligomerization

Steven D. Burke, Charles R. Heap, Warren J. Porter et al. · Tetrahedron Letters · 1996 · 15 citations

, , +12

Discovery of pyrrolo-benzo-1,4-diazines as potent Nav1.7 sodium channel blockers

Ginny D. Ho, Deen Tulshian, Ana Bercovici et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 13 citations · Full text

, , +11

1–5 of 6